Uridine and its nucleotides: Biological actions, therapeutic potentials

Trends in Pharmacological Sciences

Volumn 20, Issue 5, 1999, Pages 218-225

  Connolly, Gerald P ^a   Duley, John A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HALOPERIDOL; PLACEBO; URIDINE DERIVATIVE; URIDINE DIPHOSPHATE GLUCOSE; PYRIMIDINE NUCLEOTIDE; URIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; CANCER THERAPY; CARDIOVASCULAR DISEASE; CATABOLISM; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME ACTIVITY; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; INFERTILITY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; NONHUMAN; NUCLEOTIDE METABOLISM; ORAL DRUG ADMINISTRATION; PARKINSONISM; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PYRIMIDINE METABOLISM; RAT; REVIEW; SCHIZOPHRENIA; TREATMENT INDICATION; ANTICONVULSANT ACTIVITY; ANXIETY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CYSTIC FIBROSIS; PERIPHERAL NERVOUS SYSTEM; REPRODUCTION; TRANQUILIZING ACTIVITY;

ANIMALS; HUMANS; URACIL NUCLEOTIDES; URIDINE;

EID: 0032992733     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01298-5     Document Type: Review

References (65)

1. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D., eds (1995) in The Metabolic and Molecular Bases of Inherited Disease (Vol. II) (7th edn.), McGraw-Hill.
2. Wood A.W., Becker M.A., Minna J.D., Seegmiller J.E. Proc. Natl. Acad. Sci. U. S. A. 70:1973;3880-3883.
3. Geiger A., Yamasaki S. J. Neurochem. 1:1956;93-100.
4. Becroft D.M.O., Philips L.I., Simmonds A. Pediatr. Pharmacol. Ther. 75:1969;885-891.
5. Seifert R., Schultz G. Trends Pharmacol. Sci. 10:1989;365-369.
6. Barnard E.A., Simon J., Webb T.E. Mol. Neurobiol. 15:1997;103-129.
7. Communi D., Pirotton S., Parmentier M., Boeynaems J.M. J. Biol. Chem. 70:1995;30849-30852.
8. Anderson C.M., Parkinson F.E. Trends Pharmacol. Sci. 18:1997;387-392.
9. Enomoto K., Furuya K., Yamagishi S., Oka T., Maeno T. Pflügers Arch. 427:1994;533-542.
10. Lazarowski E.R., Homolya L., Boucher R.C., Harden T.K. J. Biol. Chem. 272:1997;24348-24354.
11. Connolly G.P., Demaine C., Duley J.A. Adv. Exp. Med. Biol. 431:1998;769-776.
12. Harden T.K., Lazarowski E.R., Boucher R.C. Trends Pharmacol. Sci. 18:1997;43-46.
13. Van Groeningen C.J., Peters G.J., Nadal J.C., Laurensse E., Pinedo H.M. J. Natl. Cancer Inst. 83:1991;437-441.
14. Gerrits G.P.J.M. et al. Nephron. 58:1991;310-314.
15. Traut T.W. Mol. Cell. Biochem. 140:1994;1-22.
16. Goetz U., Da Prada M., Pletscher A. J. Pharmacol. Exp. Ther. 178:1971;210-215.
17. Berman P., Harley E. Adv. Exp. Med. Biol. 165:1984;367-371.
18. Kelsen D.P. et al. J. Clin. Oncol. 15:1997;1511-1517.
19. Olivier K.N. et al. Am. J. Respir. Crit. Care Med. 154:1996;217-223.
20. Knowles M.R., Clarke L.L., Boucher R.C. New Engl. J. Med. 325:1991;533-538.
21. Coltorti M. Clin. Ther. 72:1975;323-335.
22. Castellani A., Colafelice M., Fichera M. Clin. Ther. 86:1978;567-576.
23. Okolicsanyi L., Orlando R., Lirussi F., Naccarato R., Dal Brun G. Clin. Ther. 93:1980;431-438.
24. Codacci-Pisanelli G. et al. Clin. Cancer Res. 3:1997;309-315.
25. Van-Groeningen C.J., Leyva A., Kraal I., Peters G.J., Pinedo H.M. Cancer Treat. Rep. 70:1986;745-750.
26. Peters G.J. et al. Pharmacol. Res. 4:1987;113-119.
27. Falcone A. et al. Blood. 76:1990;2216-2221.
28. Page T., Yu A., Fontanesi J., Nyhan W.L. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11601-11606.
29. Parenti F. Clin. Neuropharmacol. 15:1992;369-372.
30. Bonavita V., Piccoli F., Savettieri G., Zito M. Acta Neurol. 30:1975;30-34.
31. Gallai V., Mazzzotta G., Montesi S., Sarchielli P., Del Gatto F. Acta Neurol. Scand. 86:1992;3-7.
32. Valentine W.N., Fink K., Paglia D.E., Harris S.R., Adams W.S. J. Clin. Invest. 54:1974;866-879.
33. Paglia D.E., Valentine W.N., Nakatani M., Rauth B.J. Proc. Natl. Acad. Sci. U. S. A. 80:1983;3081-3085.
34. Laurence A. et al. Adv. Exp. Med. Biol. 431:1998;155-159.
35. Persson B.E., Sjoman M., Niklasson F., Ronquist G. Eur. Urol. 19:1991;253-256.
36. Ronquist G., Niklasson F. Arch. Androl. 13:1984;63-70.
37. Ronquist G., Stegmayr B., Niklasson F. Arch. Androl. 15:1985;21-27.
38. Tomlins A.M. et al. Biochim. Biophys. Acta. 1379:1998;367-380.
39. Minelli A., Moroni M., Mezzasoma I. Biochem. Mol. Med. 61:1997;95-101.
40. Xuma M., Turkington R.W. Endocrinology. 91:1972;415-422.
41. Leyva A. et al. Cancer Res. 44:1984;5928-5933.
42. Calabresi P. et al. Blood. 76:1990;2210-2215.
43. Keilbaugh S.A., Hobbs G.A., Simpson M.V. Mol. Pharmacol. 44:1993;702-706.
44. Watabe T. J. Toxicol. Sci. 21:1996;299-300.
45. Gonzalez F.J., Fernandez-Salguero P. Trends Pharmacol. Sci. 16:1995;325-327.
46. Connolly G.P., Simmonds H.A., Duley J.A. Trends Pharmacol. Sci. 17:1996;106-107.
47. Connolly G.P. Pathways to Pyrimidines. 2:1994;37-44.
48. Siggins G., Gruol D., Padjen A., Forman D. Iontophoresis and Transmitter Mechanisms Mammalian Central Nervous System. (Ryall R.W., Kelly J.S., eds), 1978;453-455 Elsevier.
49. Connolly G.P., Harrison P.J., Stone T.W. Br. J. Pharmacol. 110:1993;1297-1304.
50. Connolly G.P., Harrison P.J. Br. J. Pharmacol. 116:1995;2764-2770.
51. Boehm S., Huck S., Illes P. Br. J. Pharmacol. 116:1995;2341-2343.
52. Agnati L.F. et al. Acta Physiol. Scand. 126:1986;525-531.
53. Peters G.J. et al. Cancer Chemother. Pharmacol. 20:1987;101-108.
54. Benzi G. et al. J. Neurosci. Res. 11:1984;437-450.
55. Farabegoli C., Merlo Pich E., Cimino M., Agnati L.F., Fuxe K. Acta. PhysioI. Scand. 132:1988;209-216.
56. Agnati L. et al. Neurochem. Int. 15:1989;107-113.
57. Myers C.S., Wagner G.C., Fisher H. Pharmacol. Biochem. Behav. 52:1995;749-753.
58. Myers C.S., Napolitano M., Fisher H., Wagner G.C. Proc. Soc. Exp. Biol. Med. 204:1993;49-53.
59. Bernardini R., De Luca G., Marino D. Acta Eur. Fertil. 14:1983;341-344.
60. Karkishchenko N.N., Makliakov Y.S., Stradomskii B.V. Farmakol. Toksikol. 53:1990;67-72.
61. Guarneri P., Piccoli F., Mocciaro C., Guarneri R. Neurochem. Res. 8:1983;1537-1545.
62. Guarneri P., Guarneri R., La Bella V., Piccoli F. Epilepsia. 26:1985;666-671.
63. Kimura T. et al. Eur. J. Pharmacol. 311:1996;265-269.
64. Honda K. et al. Neurosci. Res. 1:1984;243-252.
65. Connolly G.P., Abbott N.J., Demaine C., Duley J.A. Trends Pharmacol. Sci. 18:1997;413-414.